• Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study 

      Given, Joanne E.; Loane, Maria; Garne, Ester; Addor, Marie-Claude; Bakker, Marian; Bertaut-Nativel, Bénédicte; Gatt, Miriam; Klungsøyr, Kari; Lelong, Nathalie; Morgan, Margery; Neville, Amanda J; Pierini, Anna; Rissmann, Anke; Dolk, Helen (Peer reviewed; Journal article, 2018)
      Objective: To investigate whether exposure to metformin during the first trimester of pregnancy, for diabetes or other indications, increases the risk of all or specific congenital anomalies. Design: Population based ...
    • Prevalence of congenital heart defects in Europe, 2008–2015: A registry-based study 

      Mamasoula, Chrysovalanto; Addor, Marie-Claude; Carbonell, Clara Cavero; Dias, Carlos M.; Echevarría-González-de-Garibay, Luis-Javier; Gatt, Miriam; Khoshnood, Babak; Klungsøyr, Kari; Randall, Kay; Stoianova, Sylvia; Haeusler, Martin; Nelen, Vera; Neville, Amanda J.; Perthus, Isabelle; Pierini, Anna; Bertaut-Nativel, Bénédicte; Rissmann, Anke; Rouget, Florence; Schaub, Bruno; Tucker, David; Wellesley, Diana; Zymak-Zakutnia, Natalya; Barisic, Ingeborg; de Walle, Hermien E.K.; Lanzoni, Monica; Mullaney, Carmel; Pennington, Lindsay; Rankin, Judith (Journal article; Peer reviewed, 2022)
      Background The total prevalence of congenital heart defects (CHDs) varies by populations and over time. Studies that examine trends in the prevalence of CHD in different regions may shed light on our understanding of the ...